256234-27-2 Usage
Uses
Used in Biological Research:
3-[2-(N,N-DIETHYL-N-METHYLAMMONIUM)ETHYL]-7-METHOXY-4-METHYLCOUMARIN IODIDE is used as a fluorescent dye for staining nucleic acids and cell membranes. Its fluorescent properties allow for the visualization and tracking of these biological structures, facilitating various research studies.
Used in Chemical Probing:
In the field of biochemistry, 3-[2-(N,N-DIETHYL-N-METHYLAMMONIUM)ETHYL]-7-METHOXY-4-METHYLCOUMARIN IODIDE serves as a chemical probe for detecting specific biomolecules. Its ability to bind and fluoresce in the presence of target molecules makes it a valuable tool for identifying and quantifying these biomolecules in complex biological systems.
Used in Medical Imaging:
3-[2-(N,N-DIETHYL-N-METHYLAMMONIUM)ETHYL]-7-METHOXY-4-METHYLCOUMARIN IODIDE is used as a contrast agent in medical imaging techniques. Its fluorescent characteristics enhance the visibility of internal structures and functions within the body, aiding in the diagnosis and monitoring of various medical conditions.
Used in Pharmaceutical Development:
Although not explicitly mentioned in the provided materials, given its properties and applications, 3-[2-(N,N-DIETHYL-N-METHYLAMMONIUM)ETHYL]-7-METHOXY-4-METHYLCOUMARIN IODIDE could potentially be used in the development of new pharmaceuticals, particularly those that require fluorescent tagging for tracking drug delivery and distribution within the body.
Check Digit Verification of cas no
The CAS Registry Mumber 256234-27-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,5,6,2,3 and 4 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 256234-27:
(8*2)+(7*5)+(6*6)+(5*2)+(4*3)+(3*4)+(2*2)+(1*7)=132
132 % 10 = 2
So 256234-27-2 is a valid CAS Registry Number.
256234-27-2Relevant academic research and scientific papers
REAGENTS FOR CYP2D FLUORESCENT ASSAY
-
Page 14, (2010/02/05)
Novel fluorescent substrates of the human P450 enzyme CYP2D6 are provided. Also provided are methods for their manufacture and use. These substrates are useful in assessing CYP2D6 enzyme activity and in selecting compounds which inhibit CYP2D6 enzyme activity and, in particular, for identifying potential adverse drug interactions which are mediated by inhibition of CYP2D6 enzyme activity.
